![[CCO] Certification Coaching Organization LLC](https://staging.cco.us/wp-content/uploads/2015/05/CCO-Logo-2015-d3-500px.png "[CCO] Certification Coaching Organization LLC"){kind=logo}
This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive coding, clinical, and documentation guidance for common conditions of the ear — encompassing the external ear (H60–H62), middle ear and mastoid (H65–H75), inner ear (H80–H83), and other ear disorders including hearing loss (H90–H93). Content reflects FY2026 ICD-10-CM guidelines (effective October 1, 2025 – September 30, 2026) and incorporates current epidemiological, clinical, and CPT coding resources. Use this guide to ensure accurate diagnosis code assignment, appropriate CDI query triggers, and defensible documentation across all ear-related encounters.
1. Definition
Common conditions of the ear span four anatomical regions: the external ear (auricle, external auditory canal), the middle ear (tympanic membrane, ossicles, Eustachian tube, mastoid), the inner ear (cochlea, vestibular apparatus), and the auditory/vestibulocochlear nerve pathways. ICD-10-CM Chapter 8 (H60–H95) classifies diseases of the ear and mastoid process, and this guide covers the most clinically significant conditions encountered across primary care, ENT/otolaryngology, audiology, and urgent care settings.
Otitis externa (H60.x) is inflammation of the external auditory canal, ranging from acute diffuse infection ("swimmer's ear") to malignant (necrotizing) otitis externa — a life-threatening skull-base osteomyelitis predominantly affecting immunocompromised patients, as defined by StatPearls/NCBI.
Otitis media (H65–H67) encompasses nonsuppurative (serous, mucoid, allergic) and suppurative (acute, chronic tubotympanic, chronic atticoantral) middle ear inflammation. Otitis media is among the most common diagnoses in ambulatory pediatric care, per CDC antibiotic stewardship guidance.
Cholesteatoma (H71.x) is a destructive epidermal cyst of the middle ear or mastoid that erodes bone and surrounding structures, requiring surgical management. It must be distinguished from granulation tissue for accurate coding and CDI documentation.
Hearing loss (H90–H91) includes conductive, sensorineural, mixed, and age-related (presbycusis) forms as well as sudden idiopathic sensorineural hearing loss (SSNHL). Accurate laterality and type documentation directly affect risk adjustment tracking for dual-eligible Medicare beneficiaries.
Vestibular disorders (H81.x) — including Ménière's disease and benign paroxysmal positional vertigo (BPPV) — generate significant diagnostic and procedural coding complexity due to overlapping symptomatology with central causes of vertigo.
2. Alternative Terminology
| Formal / ICD-10-CM Name | Colloquial / Lay / Clinical Synonyms |
|---|---|
| Otitis externa, diffuse (H60.31x) | Swimmer's ear, external ear infection, acute diffuse OE |
| Malignant otitis externa (H60.2x) | Necrotizing OE, skull-base osteomyelitis (otogenic), invasive OE |
| Cholesteatoma of external ear (H60.4x) | Keratosis obturans, external ear cholesteatoma |
| Acute serous otitis media (H65.0x) | Ear fluid, glue ear (acute), acute secretory OM, acute OME |
| Chronic mucoid otitis media (H65.3x) | Glue ear, chronic OME, middle ear effusion (chronic) |
| Acute suppurative otitis media (H66.0x) | Acute bacterial OM, AOM, purulent OM, ear infection |
| Chronic tubotympanic suppurative OM (H66.1x) | Benign chronic OM, chronic suppurative OM (safe), CSOM-tubotympanic |
| Chronic atticoantral suppurative OM (H66.2x) | Dangerous chronic OM, CSOM-atticoantral, unsafe OM |
| Cholesteatoma of middle ear (H71.x) | Middle ear cholesteatoma, acquired cholesteatoma, epidermal cyst middle ear |
| Tympanic membrane perforation (H72.x) | Ruptured eardrum, TM perforation, perforated drum |
| Mastoiditis (H70.x) | Acute/chronic mastoiditis, coalescent mastoiditis, postauricular abscess |
| Otosclerosis (H80.x) | Otospongiosis, stapes fixation, conductive hearing loss from otosclerosis |
| Ménière's disease (H81.0x) | Endolymphatic hydrops, Ménière syndrome, labyrinthine hydrops |
| Benign paroxysmal positional vertigo (H81.1x) | BPPV, canalith repositioning vertigo, posterior canal BPPV |
| Conductive hearing loss (H90.0–H90.2) | CHL, conduction deafness, ossicular chain hearing loss |
| Sensorineural hearing loss (H90.3–H90.5) | SNHL, nerve deafness, inner ear hearing loss |
| Presbycusis (H91.1x) | Age-related hearing loss, ARHL, senile deafness |
| Sudden idiopathic hearing loss (H91.2x) | SSNHL, sudden deafness, acute SNHL |
| Otalgia (H92.0x) | Ear pain, earache, aural pain |
| Tinnitus (H93.1x) | Ringing in ears, ear ringing, head noise |
3. Signs & Symptoms
External Ear Conditions
- Otitis externa: Otalgia (often severe, worsened by tragal pressure or jaw movement), otorrhea, pruritus, external canal edema and erythema, possible conductive hearing loss from canal occlusion. Malignant OE presents with granulation tissue at the bony-cartilaginous junction, cranial nerve palsies (VII most common), and evidence of skull base involvement on CT/MRI per NCBI StatPearls.
- Impacted cerumen (H61.2x): Aural fullness, hearing loss, otalgia, tinnitus, vertigo.
- Perichondritis (H61.0x): Erythema, swelling, and tenderness of the auricle; fever; risk of auricular deformity ("cauliflower ear") if untreated.
Middle Ear Conditions
- Acute suppurative OM (H66.0x): Rapid-onset otalgia, fever, bulging erythematous tympanic membrane, otorrhea with TM rupture, reduced hearing. Recurrent AOM = 3+ episodes in 6 months or 4+ in 12 months per AAP clinical practice guidelines.
- Otitis media with effusion (H65.x): Aural fullness, mild conductive hearing loss, crackling sounds; tympanic membrane may show air-fluid levels or retraction; often asymptomatic in children.
- Chronic suppurative OM (H66.1x–H66.3x): Persistent/recurrent painless otorrhea (tubotympanic) or foul-smelling discharge with attic perforation (atticoantral), gradual hearing loss, possible cholesteatoma.
- Cholesteatoma (H71.x): Foul-smelling otorrhea, conductive hearing loss, white keratinous debris in attic or postauricular area, possible vertigo/SNHL with inner ear erosion, facial nerve weakness (if eroding facial canal).
- Mastoiditis (H70.x): Postauricular erythema, tenderness, fluctuance; anterior/inferior ear displacement; fever; preceding or concurrent AOM. Complications include subperiosteal abscess, sigmoid sinus thrombosis, meningitis.
Inner Ear & Hearing Loss
- Ménière's disease (H81.0x): Episodic vertigo (20 min – 12 hr), fluctuating low-frequency SNHL, tinnitus, aural fullness — the classic tetrad per AAO-HNS clinical practice guidelines.
- BPPV (H81.1x): Brief (seconds) rotational vertigo triggered by head position changes; positive Dix-Hallpike test; no hearing loss or tinnitus.
- Sudden SNHL (H91.2x): Unilateral hearing loss occurring within 72 hours, often awakening with hearing loss; may be accompanied by tinnitus and/or vertigo; requires urgent workup per AAO-HNS SSNHL guidelines.
- Presbycusis (H91.1x): Gradual bilateral symmetric high-frequency SNHL; difficulty understanding speech in noise; progressive over years.
- Otosclerosis (H80.x): Progressive conductive hearing loss (young adults, more common in females); Carhart's notch on audiogram; normal tympanogram; positive Schwartze sign (flamingo pink blush through TM) in active cochlear otosclerosis.
Otorrhea (H92.1x) and otalgia (H92.0x) are symptom codes — do NOT code them separately when a definitive diagnosis (e.g., AOM, chronic OM) is documented. Per ICD-10-CM Official Guidelines Section I.C, signs and symptoms integral to a confirmed condition are not coded additionally.
4. Differential Diagnosis
| Presenting Complaint | Primary Diagnosis to Consider | Key Differentiating Features |
|---|---|---|
| Ear pain + canal discharge | Otitis externa vs. AOM with TM rupture | OE: pain with tragal pressure, edematous canal; AOM rupture: prior otalgia/fever, central TM perforation with mucopurulent discharge |
| Ear pain + intact TM | Referred otalgia (dental, TMJ, cervical, pharyngeal) | Normal otoscopic exam; pain on jaw movement or tooth percussion; check CN V, IX, X pathways; H92.09 otalgia unspecified until etiology confirmed |
| Chronic painless otorrhea | Cholesteatoma vs. chronic suppurative OM (tubotympanic) | Cholesteatoma: attic/postauricular perforation, white debris, bone erosion on CT; tubotympanic CSOM: central perforation, mucoid discharge, no keratin |
| Sudden unilateral SNHL | Sudden idiopathic SNHL vs. acoustic neuroma vs. Ménière's | SSNHL: acute onset within 72 hr, no mass on MRI; acoustic neuroma (D14.0/H93.3): progressive, MRI gadolinium enhancement; Ménière's: episodic with vertigo tetrad |
| Episodic vertigo | BPPV vs. Ménière's vs. vestibular neuritis vs. central | BPPV: seconds, triggered by position change, positive Dix-Hallpike; Ménière's: minutes–hours, with hearing loss; vestibular neuritis: days, no hearing loss; central: direction-changing nystagmus, neurological signs |
| Progressive conductive HL | Otosclerosis vs. ossicular discontinuity vs. cholesteatoma | Otosclerosis: normal TM, Carhart notch; ossicular discontinuity: history of trauma/OM, type Ad tympanogram; cholesteatoma: retraction pocket/debris |
| Postauricular swelling + ear displacement | Mastoiditis vs. postauricular lymphadenitis vs. sebaceous cyst | Mastoiditis: preceding AOM, loss of postauricular crease, CT shows mastoid opacification ± coalescence; lymphadenitis: nodes palpable, less erythema; sebaceous cyst: no pain, no canal changes |
| Bilateral high-frequency HL (elderly) | Presbycusis vs. noise-induced HL vs. ototoxic HL | Presbycusis: gradual, symmetric, age-related; NIHL: notch at 4 kHz, occupational history; ototoxic: drug exposure history (aminoglycosides, cisplatin, loop diuretics) |
5. Clinical Indicators for Coders/CDI
| Clinical Indicator | Documentation Requirement | Coding Impact |
|---|---|---|
| Laterality | Right, left, bilateral, or unspecified for all ear codes | Most H60–H93 codes require 7th-character laterality; "unspecified" codes carry audit risk and potential query trigger |
| Acute vs. chronic OM | Duration, prior episodes, treatment response, TM status | Acute (H66.0x) vs. chronic tubotympanic (H66.1x) vs. chronic atticoantral (H66.2x) drive different MS-DRGs and severity levels |
| Suppurative vs. nonsuppurative OM | TM appearance (bulging/purulent vs. retraction with effusion), culture results | H65.x (nonsuppurative) vs. H66.x (suppurative); suppurative OM with TM perforation requires additional H72.x code |
| Cholesteatoma vs. granulation tissue | Surgical/otoscopic description of keratin debris, bone erosion, pathology report | H71.x (cholesteatoma) vs. H70.1x (granulation tissue) — dramatically different surgical CPT code selection and MS-DRG assignment |
| Recurrent OM | Number of episodes with dates; 3+ in 6 mo or 4+ in 12 mo = recurrent | Recurrent AOM (H66.004–H66.007) justifies tympanostomy tube placement (CPT 69436) |
| Type of hearing loss | Audiogram results: conductive, sensorineural, mixed; laterality; pure-tone averages | H90.0–H90.8 (conductive/sensorineural/mixed); impacts hearing aid eligibility, cochlear implant candidacy, dual-eligible risk tracking |
| Malignant OE vs. acute OE | Immunocompromised status (diabetes, HIV), culture (Pseudomonas), CT findings, granulation tissue | H60.2x (malignant OE) triggers significantly higher resource utilization codes and longer LOS than H60.3x (other infective OE) |
| Spontaneous TM rupture with AOM | Documentation of rupture vs. pre-existing perforation | H66.01x (AOM with spontaneous rupture) requires separate H72.x code for the TM perforation; pre-existing perforation = H72.x primary |
| Device complications | CI malfunction, tube extrusion, implant erosion | T85.6xx (device complications) coded with external cause and laterality; distinguish complication from expected postoperative change |
Laterality not specified in ear conditions: The record documents otitis media but does not specify which ear. According to AHA Coding Clinic and ICD-10-CM guidelines, laterality must be documented to assign the most specific code. Please clarify: Is the otitis media affecting the (a) right ear, (b) left ear, or (c) bilateral?
6. Anatomy & Pathophysiology
Anatomical Overview
The ear is divided into three functional regions as described by NCBI StatPearls ear anatomy review:
- External ear: Auricle (pinna) and external auditory canal (EAC). The EAC is approximately 2.5 cm long, with a cartilaginous outer third and bony inner two-thirds. The EAC is lined with squamous epithelium and contains hair follicles and ceruminous glands. The EAC terminates at the tympanic membrane.
- Middle ear (tympanic cavity): An air-filled space containing the ossicular chain (malleus, incus, stapes) that mechanically amplifies and transmits sound from the tympanic membrane to the oval window. The Eustachian tube (pharyngotympanic tube) connects the middle ear to the nasopharynx, equalizing pressure and draining secretions. The mastoid process communicates with the middle ear via the aditus ad antrum.
- Inner ear: The cochlea (hearing) and vestibular labyrinth (balance — semicircular canals, utricle, saccule) embedded within the petrous temporal bone. The cochlea contains the organ of Corti with hair cells that transduce mechanical vibrations into neural impulses via the vestibulocochlear nerve (CN VIII).
Key Pathophysiological Mechanisms
- Otitis externa: Disruption of the acidic, cerumen-protective environment of the EAC (by moisture, mechanical trauma, or hearing aids) allows bacterial overgrowth — predominantly Pseudomonas aeruginosa (40%) and Staphylococcus aureus (30%). Malignant OE involves contiguous osteomyelitis of the skull base driven by P. aeruginosa in diabetic/immunocompromised hosts, per NCBI StatPearls malignant OE.
- Otitis media: Eustachian tube dysfunction (ETD) leads to negative middle ear pressure, fluid accumulation (OME), or bacterial superinfection (AOM). Common pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis. Recurrent/untreated AOM may progress to chronic suppurative OM with TM perforation and, in the atticoantral type, cholesteatoma formation.
- Cholesteatoma: Abnormal keratinizing squamous epithelium in the middle ear/mastoid; acquired type most commonly arises from Eustachian tube dysfunction and TM retraction pockets. Progressive bone erosion via osteoclast-activating enzymes (collagenases, IL-1, TNF-α) can destroy the ossicular chain, labyrinth, facial canal, and tegmen.
- Hearing loss: Conductive HL results from disorders affecting the outer/middle ear (OE, OM, TM perforation, otosclerosis, ossicular discontinuity). SNHL results from damage to the cochlear hair cells or CN VIII (noise exposure, ototoxicity, aging, viral infection). Mixed HL has both components. Sudden SNHL may reflect viral cochleitis, vascular ischemia, or perilymphatic fistula.
- Ménière's disease: Endolymphatic hydrops (excess endolymph in the scala media of the cochlea and vestibular end-organs) disrupts the endocochlear potential, causing episodic dysfunction. The etiology is multifactorial (immune, genetic, vascular) per AAO-HNS Ménière's clinical practice guideline.
- BPPV: Detached otoconia (calcium carbonate crystals) from the utricle migrate into semicircular canals (most commonly posterior), generating abnormal endolymph displacement during head movement and transient vertigo via ampullary hair cell stimulation.
- Otosclerosis: Abnormal bone remodeling of the otic capsule — normally resistant to bone turnover — leads to new spongy bone formation (otospongiosis) that fixes the stapes footplate in the oval window, impairing sound transmission and causing conductive/mixed HL.
7. Medication Impact / Treatment
Pharmacological Treatments
| Condition | Medication Class / Agent | Documentation / Coding Impact |
|---|---|---|
| Otitis externa (acute) | Topical fluoroquinolone (ciprofloxacin/dexamethasone — Ciprodex®); acetic acid/hydrocortisone; topical aminoglycosides (avoid with TM perforation) | Topical antibiotic use confirms active infection; ototoxic drops contraindicated with perforation — documents care quality metric |
| Malignant OE | IV/oral anti-pseudomonal antibiotics (ciprofloxacin 750 mg BID × 6–8 wk; piperacillin-tazobactam for IV); hyperbaric oxygen as adjunct | IV antibiotics confirm severity; prolonged treatment course affects LOS and CC/MCC assignment |
| AOM | Amoxicillin (first-line per AAP guidelines); amoxicillin-clavulanate for treatment failure; observation appropriate for mild/moderate in ≥2 y.o. | Antibiotic selection documents bacteriologic assumption; "watchful waiting" must be documented to avoid coding as untreated infection |
| OME (glue ear) | Observation (first-line for ≤3 months); autoinflation; nasal corticosteroids (adjunct); antibiotics/antihistamines NOT recommended per AAP | Duration of effusion and audiologic impact must be documented to justify tube placement; H65.x + audiogram findings support surgical CDG |
| Ménière's disease | Low-sodium diet; diuretics (hydrochlorothiazide/triamterene); betahistine (not FDA-approved); intratympanic steroids; intratympanic gentamicin (destructive); endolymphatic sac surgery | Diuretic use and dietary modifications are conservative treatment documentation; intratympanic procedures coded separately (CPT 69800–69806) |
| BPPV | Canalith repositioning (Epley maneuver — primary treatment); vestibular suppressants (meclizine) — SHORT-TERM only; physical therapy | Epley maneuver is a therapeutic procedure (CPT 95992); medication dependency vs. repositioning response affects ongoing coding |
| Sudden SNHL | Oral corticosteroids (prednisone 1 mg/kg/day × 10–14 days — AAO-HNS first-line recommendation); intratympanic dexamethasone (salvage); hyperbaric oxygen | Steroid course confirms clinical diagnosis; intratympanic injection = CPT 69801 or 69802; corticosteroid-related complications must be separately coded |
| Otosclerosis | Sodium fluoride (stabilizes bone remodeling — limited evidence); hearing aids (conservative); surgical stapedectomy/stapedotomy (definitive) | Medical management vs. surgical approach must be clearly documented; fluoride therapy use does not change the diagnosis code but documents severity/progression |
| Ototoxicity-induced HL (H91.0x) | Offending agent identification and discontinuation/modification; no FDA-approved otoprotective agents currently available | H91.0x requires additional code for the adverse effect of the causative drug (T-code with 5th/6th character 5); document the specific agent |
Ototoxic hearing loss coding sequence: When hearing loss is caused by a drug adverse effect (e.g., aminoglycosides, cisplatin, loop diuretics), code H91.0x first, then the adverse effect T-code (with 5th/6th character "5"). Do NOT sequence the T-code first for adverse effects — this is a common sequencing error per AHA Coding Clinic.
Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
🔒 Register or sign in to read the full guide
Unlock the full guide including:
- • 📘 8. ICD-10-CM Guidelines (FY2026)
- • 🔢 9. ICD-10-CM Code Set (FY2026)
- • 🔎 10. Indexing
- • 🏥 11. CPT (2026)
- • 🧾 12. HCPCS (2026)
- • 📚 13. AHA Coding Clinic (Recent Guidance)
- • 💰 14. HCC / Risk Adjustment (v28)
- • ✍️ 15. CDI Query Templates
- • 🧑⚕️ 16. Treatments (Clinical)
- • 🎓 17. Patient Education / Summary
